Trial site
Instituto de Pesquisa Clínica de Campinas
- 19running trials
- 14closed trials
The trials here
What the 35 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes13 trials
- Obesity11 trials
- Chronic kidney disease5 trials
- Coronary artery disease5 trials
- Heart failure5 trials
- Stroke4 trials
- Peripheral artery disease2 trials
- Type 1 diabetes2 trials
- Alzheimer disease1 trial
- Atrial fibrillation1 trial
- Bipolar disorder1 trial
- Depression1 trial
- and 4 more
- Phase
- Phase 329 trials
- Phase 24 trials
- Phase 41 trial
- Status
- Completed13 trials
- Recruiting8 trials
- Not yet recruiting7 trials
- Active, not recruiting4 trials
- Suspended2 trials
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company18 trials
- Novo Nordisk A/S8 trials
- Amgen2 trials
- Hospital Israelita Albert Einstein2 trials
- Janssen Research & Development, LLC2 trials
- and 3 more
Running trials
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
Recruiting
Recruiting
Recruiting
A Study of Brenipatide in Adult Participants With Schizophrenia
Recruiting
Recruiting
Recruiting
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Active, not recruiting
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes5 recruiting
- Obesity3 recruiting
- Chronic kidney disease2 recruiting
- Heart failure2 recruiting
- Alzheimer disease1 recruiting
- Bipolar disorder1 recruiting
- Depression1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Peripheral artery disease1 recruiting
- Schizophrenia1 recruiting
- Stroke1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
Completed
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026